Brain Cancer

The plan to launch the phase 1 trial to evaluate the safety and efficacy of combining the CAR-T cell therapy and oncolytic virus in patients with recurrent glioblastoma, a type of brain cancer, is supported by interim data from two ongoing trials.

The study authors plan to enroll 24 patients with glioblastoma, an aggressive brain tumor, to assess the efficacy an investigational drug plus Libtayo prior to surgery to remove the tumor.

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

A brain cancer survivor explains how she found a way to navigate her cancer journey as a traveler, grateful to be alive.

A brain tumor survivor explains how she chooses to approach life with acceptance of the hard times rather than trying to throw them away.

Patients with a common brain tumor subtype that expresses ERK1/2 activation may obtain a greater survival benefit with PD-1 immunotherapy, although research needs to confirm whether this can be observed in all patients.

From celebrity deaths to exciting new treatments, here is CURE®’s roundup of what made waves in the brain cancer space this year.

Upon recognizing the 50th anniversary of the National Cancer Act of 1971, President Joe Biden set forth his proposal for the Advanced Research Projects Agency for Health.

From the deaths of Jovita Moore and Jerry Remy due to cancer, to Boyd Huppert’s myeloma diagnosis, here’s what’s happening in the cancer landscape this week.

When a patient’s cancer spreads to the brain, their original cancer type may predict what region of the brain the metastasis occurs in, according to new findings. The research could lead to better treatment approaches in the future.

Brain metastases are a pattern of spread we are seeing more for many tumor types as patients are living longer with metastatic cancer and we more readily use an array of brain imaging technologies when needed.

The FDA granted approval to Welireg for the treatment of patients with von Hippel-Lindau-associated kidney cancer, CNS hemangioblastomas and pancreatic neuroendocrine tumors.

The vaccine significantly improved a survival outcome over standard-of-care treatment in patients with newly diagnosed glioblastoma.

A long-term brain cancer survivor shares the story of his cancer journey and where it led his life.

In honor of Brain Cancer Awareness Month, CURE® spoke with an expert about the latest advances that researchers are working on for patients with this disease.

From a mural of Chadwick Boseman in a Los Angeles children’s hospital to the death of Apollo 11 astronaut Michael Collins, here’s what’s happening in the cancer landscape this week.

From a 5-year-old with brain cancer celebrating his final round of radiation at a hockey game to a cancer diagnosis for Exodus drummer Tom Hunting, here’s what’s happening in the cancer landscape this week.

The FDA has recommended the manufacturer of a cell-based immunotherapy terminate a phase 2 clinical trial assessing its effectiveness in recurrent or progressive glioblastoma early and pursue a phase 3 trial which may lead to an approval.

The American Brain Tumor Association offers a wealth of online resources for patients with metastatic brain tumors and their loved ones and caregivers.